Literature DB >> 24929655

Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.

Esmée Vendel1, Elizabeth C M de Lange.   

Abstract

The cannabinoid (CB) receptors are the main targets of the cannabinoids, which include plant cannabinoids, endocannabinoids and synthetic cannabinoids. Over the last few years, accumulated evidence has suggested a role of the CB receptors in neuroprotection. The blood-brain barrier (BBB) is an important brain structure that is essential for neuroprotection. A link between the CB receptors and the BBB is thus likely, but this possible connection has only recently gained attention. Cannabinoids and the BBB share the same mechanisms of neuroprotection and both protect against excitotoxicity (CB1), cell death (CB1), inflammation (CB2) and oxidative stress (possibly CB independent)-all processes that also damage the BBB. Several examples of CB-mediated protection of the BBB have been found, such as inhibition of leukocyte influx and induction of amyloid beta efflux across the BBB. Moreover, the CB receptors were shown to improve BBB integrity, particularly by restoring the tightness of the tight junctions. This review demonstrated that both CB receptors are able to restore the BBB and neuroprotection, but much uncertainty about the underlying signaling cascades still exists and further investigation is needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24929655     DOI: 10.1007/s12017-014-8314-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  212 in total

Review 1.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

Authors:  M Shen; S A Thayer
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

Review 4.  Cellular signal transduction by anandamide and 2-arachidonoylglycerol.

Authors:  A C Howlett; S Mukhopadhyay
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

5.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

Authors:  Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla
Journal:  Brain Res       Date:  2010-03-01       Impact factor: 3.252

6.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.

Authors:  Oak Z Chi; Sylviana Barsoum; Jeremy Grayson; Christine Hunter; Xia Liu; Harvey R Weiss
Journal:  Pharmacology       Date:  2012       Impact factor: 2.547

8.  [Reactive oxygen species and inflammation].

Authors:  J Hakim
Journal:  C R Seances Soc Biol Fil       Date:  1993

9.  Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.

Authors:  Yan Wei; Xu Wang; Feng Zhao; Pei-Quan Zhao; Xiao-Li Kang
Journal:  Mol Vis       Date:  2013-02-13       Impact factor: 2.367

10.  p38 MAPK mediates calcium oxalate crystal-induced tight junction disruption in distal renal tubular epithelial cells.

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2013-01-09       Impact factor: 4.379

View more
  15 in total

Review 1.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 2.  The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.

Authors:  Javier Fernández-Ruiz
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

3.  Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.

Authors:  Srinidhi Jayaraman; Abdullah Al Shoyaib; Joanna Kocot; Heidi Villalba; Faisal F Alamri; Mamoon Rashid; Naomi J Wangler; Ekram A Chowdhury; Nadezhda German; Thiruma V Arumugam; Thomas J Abbruscato; Vardan T Karamyan
Journal:  J Neurochem       Date:  2019-10-22       Impact factor: 5.372

4.  Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid system protects against colitis and ameliorates remote organ lesions in mice.

Authors:  Xiaolin Zhao; Peng Liang; Jin Liu; Haixia Jiang; Xiaoshuai Fan; Guo Chen; Cheng Zhou
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

5.  Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors.

Authors:  Anamaria Falcão Pereira; Mario Roberto Pontes Lisboa; Bruno Wesley de Freitas Alves; Cristiane Maria Pereira da Silva; Diego Bernarde Souza Dias; Karoline Luanne Santos de Menezes; Francisco Rafael Alves Santana Cesário; Jonas Costa de França; Amanda Rocha de Oliveira; Jaime Eduardo Cecilio Hallak; Antonio Waldo Zuardi; José Alexandre Crippa; Nylane Maria Nunes de Alencar; Roberto César Pereira Lima-Júnior; Mariana Lima Vale
Journal:  Neurotox Res       Date:  2021-11-18       Impact factor: 3.911

Review 6.  Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Mol Neurodegener       Date:  2015-04-08       Impact factor: 14.195

7.  Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior.

Authors:  Kathryn J Argue; Jonathan W VanRyzin; David J Falvo; Allison R Whitaker; Stacey J Yu; Margaret M McCarthy
Journal:  eNeuro       Date:  2017-01-27

Review 8.  Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.

Authors:  Tommaso Cassano; Silvio Calcagnini; Lorenzo Pace; Federico De Marco; Adele Romano; Silvana Gaetani
Journal:  Front Neurosci       Date:  2017-02-02       Impact factor: 4.677

Review 9.  Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.

Authors:  Gemma Navarro; Paula Morales; Carmen Rodríguez-Cueto; Javier Fernández-Ruiz; Nadine Jagerovic; Rafael Franco
Journal:  Front Neurosci       Date:  2016-09-13       Impact factor: 4.677

Review 10.  Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.

Authors:  Diogo M Lourenço; Leonor Ribeiro-Rodrigues; Ana M Sebastião; Maria J Diógenes; Sara Xapelli
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.